When co-cultured CD8+ T cells and human breast cancer cells (MCF-7) were used to investigate the immune response of fucoidan, it was discovered that the number of CD8+ T cells and interferon-γ (IFN-γ) was doubled in the fucoidan-treated group compared to the control [93]. This evidence concerns the gene CD8A and breast cancer.